BNP Paribas Financial Markets’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.45K | Sell |
|
|||||
|
2025
Q2 | $1.69K | Sell |
|
|||||
|
2025
Q1 | $7.19K | Sell |
|
|||||
|
2024
Q4 | $11.8K | Sell |
|
|||||
|
2024
Q3 | $29.1K | Buy |
|
|||||
|
2024
Q2 | $10.3K | Buy |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $16 | Sell |
|
|||||
|
2022
Q4 | $1.12K | Buy |
|
|||||
|
2022
Q3 | $1.18K | Sell |
|
|||||
|
2022
Q2 | $49.2K | Buy |
|
|||||
|
2022
Q1 | $10.2K | Sell |
|
|||||
|
2021
Q4 | $308K | Buy |
|
|||||
|
2021
Q3 | $39.1K | Buy |
|
|||||
|
2021
Q2 | $50.8K | Sell |
|
|||||
|
2021
Q1 | $149K | Buy |
|
|||||
|
2020
Q4 | $122K | Sell |
|
|||||
|
2020
Q3 | $1.9M | Buy |
|
|||||
|
2020
Q2 | $2.13M | Sell |
|
|||||
|
2020
Q1 | $1.64M | Buy |
|
|||||
|
2019
Q4 | $1.85M | Buy |
|
|||||
|
2019
Q3 | $47K | Buy |
|
|||||
|
2019
Q2 | $73K | Sell |
|
|||||
|
2019
Q1 | $86.5K | Buy |
|
|||||
|
2018
Q4 | $26.7K | Sell |
|
|||||
|
2018
Q3 | $143K | Sell |
|
|||||
|
2018
Q2 | $126K | Buy |
|
|||||
|
2018
Q1 | $35 | Hold |
|
|||||
|
2017
Q4 | $21 | Hold |
|
|||||
|
2017
Q3 | $22 | Hold |
|
|||||
|
2017
Q2 | $15 | Sell |
|
|||||
|
2017
Q1 | $138 | Sell |
|
|||||
|
2016
Q4 | $1.06K | Sell |
|
|||||
|
2016
Q3 | $6.38K | Buy |
|
|||||
|
2016
Q2 | $2.84K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $46.2K | Buy |
|
|||||
|
2015
Q3 | $36.2K | Sell |
|
|||||
|
2015
Q2 | $507K | Buy |
|
|||||
|
2015
Q1 | $6.2K | Buy |
|